Research on people and animals has shown that gut bacteria undergo major changes after the surgery
Check out the study here: Kraemer et al., 2006
Biopsy-confirmed DIO-NASH mouse model ALT-801 was evaluated for its metabolic and anti-fibrotic effects during 12 weeks of treatment in the well-documented Amylin Liver NASH (AMLN) DIO-NASH mouse model 22,44 at Gubra ApS
Aetnas petition for the state to review its Medicaid contract decisions was rejected
The first clinical trial on DPP-4 inhibitors was published in 2002, and subsequent randomized controlled trials (RCTs) demonstrated their efficacy, safety, and tolerability (15, 17)
Clinical studies demonstrate strong correlations between OS markers and vascular complications including diabetic kidney disease (Forbes and Thorburn, 2018